Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients

Table 3 The comparison of ratio of lymphocytes to monocytes to lactate dehydrogenase in patients with different clinicopathological features

Clinicopathological features	LMR/LDH	t	P value
Sex		-1.947	0.056
Male	0.38 ± 0.10
Female	0.43 ± 0.11
Age (yr)		0.796	0.429
< 60	0.41 ± 0.09
≥ 60	0.39 ± 0.10
Ann Arbor stage		-4.799	< 0.001
I-II	0.36 ± 0.08
III-IV	0.46 ± 0.09
ECOG scores		-5.977	< .001
< 2	0.35 ± 0.09
≥ 2	0.50 ± 0.11
IPI scores		-4.366	< 0.001
0-1	0.36 ± 0.08
2-5	0.45 ± 0.09
Hans		0.853	0.397
GCB	0.41 ± 0.10
Non GCB	0.39 ± 0.09
BCL2 expression		-0.964	0.339
< 50%	0.39 ± 0.08
≥ 50%	0.41 ± 0.09
Ki-67		0.835	0.407
< 70%	0.41 ± 0.10
≥ 70%	0.39 ± 0.09

LMR: Ratio of lymphocytes to monocytes; LDH: Lactate dehydrogenase; IPI: International prognostic index; ECOG: Eastern Cooperative Oncology Group; GCB: Germinal center B-cell.